Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment

Purpose Health-related quality of life (HRQOL) has not been examined in patients with predominant antibody deficiency both pre- and post-immunoglobulin G (IgG) treatment initiation. HRQOL and health resource utilization (HRU) were assessed in newly diagnosed patients with primary immunodeficiency di...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical immunology Vol. 36; no. 5; pp. 450 - 461
Main Authors Routes, John, Costa-Carvalho, Beatriz Tavares, Grimbacher, Bodo, Paris, Kenneth, Ochs, Hans D., Filipovich, Alexandra, Hintermeyer, Mary, de Melo, Karina Mescouto, Workman, Sarita, Ito, Diane, Ye, Xiaolan, Bonnet, Patrick, Li-McLeod, Josephine
Format Journal Article
LanguageEnglish
Published New York Springer US 01.07.2016
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose Health-related quality of life (HRQOL) has not been examined in patients with predominant antibody deficiency both pre- and post-immunoglobulin G (IgG) treatment initiation. HRQOL and health resource utilization (HRU) were assessed in newly diagnosed patients with primary immunodeficiency disease (PIDD) pre- and 12 months post-IgG treatment initiation. Methods Adults (age ≥18 years) completed the 36-item Short Form Health Survey, version 2; pediatric patients (PP)/caregivers completed the Pediatric Quality of Life Inventory (PedsQL). Scores were compared with normative data from the US general population (GP) and patients with other chronic conditions (OCC). Results Seventeen adult patients (APs), 8 PPs, and 8 caregivers completed baseline assessments. APs had significantly lower baseline mean physical component summary scores versus GP (37.4 vs 50.5, p  < 0.01) adults with chronic back pain (44.1, p  < 0.05) or cancer (44.4, p  < 0.05) and lower mental component summary scores versus GP (41.6 vs 49.2, p  < 0.05). PPs had lower PedsQL total (63.1 vs 82.7), physical summary (64.5 vs 84.5), and psychosocial summary (62.5 vs 81.7) scores versus GP. Post-IgG treatment, 14 APs, 6 PPs, and 8 caregivers completed assessments. Hospital admissions (0.2 versus 1.8, p  < 0.01), serious infections (3.3 versus 10.9, p  < 0.01) and antibiotic prescriptions (3.0 versus 7.1; p  < 0.01) decreased significantly overall. While APs reported significant improvement in role-physical ( p  = 0.01), general health ( p  < 0.01), and social functioning ( p  = 0.02) and caregivers in vitality ( p  < 0.01), PPs did not. Conclusions Pre-IgG treatment, patients with PIDD experienced diminished HRQOL versus GP and patients with OCC; post-treatment, HRU decreased and certain HRQOL aspects improved for APs and caregivers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0271-9142
1573-2592
DOI:10.1007/s10875-016-0279-0